Gene · 3909
Papers1,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying the Pattern Characteristics of Anoikis-Related Genes in Keloid. | Adv Wound Care (New Rochelle) | 2025 | 38775414 | PubTator, text mining | PubMed |
| Leveraging Bioinformatics and Machine Learning for Identifying Prognostic Biomarkers and Predicting Clinical Outcomes in Lung Adenocarcinoma. | Genes (Basel) | 2024 | 39766765 | PubTator, text mining | PubMed |
| Prenatal Diagnosis of LAMA 3 Mutation, responsible for Junctional Epidermolysis. | J Obstet Gynaecol India | 2024 | 39758575 | PubTator, text mining | PubMed |
| Fructo-Oligosaccharides Enhance the Expression of Genes Related to Focal Adhesion- and Inflammation-Pathways in Small Intestinal Absorptive Caco-2 Cells. | J Nutr Sci Vitaminol (Tokyo) | 2024 | 39756968 | PubTator, text mining | PubMed |
| Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosa. | Mol Ther Nucleic Acids | 2024 | 39391765 | PubTator, text mining | PubMed |
| Axial length acquisition success rates and agreement of two swept-source optical biometers in eyes with dense cataracts. | Front Med (Lausanne) | 2024 | 39386744 | PubTator, text mining | PubMed |
| Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cells. | Sci Rep | 2024 | 39289406 | PubTator, text mining | PubMed |
| Comprehensive analysis and experimental verification of the mechanism of anoikis related genes in pancreatic cancer. | Heliyon | 2024 | 39253230 | PubTator, text mining | PubMed |
| TNF Induces Laminin-332-Encoding Genes in Endothelial Cells and Laminin-332 Promotes an Atherogenic Endothelial Phenotype. | Int J Mol Sci | 2024 | 39201392 | PubTator, text mining | PubMed |
| Reconstruction of single-cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition. | Proc Natl Acad Sci U S A | 2024 | 39093947 | PubTator, text mining | PubMed |
| Expression of the laminin genes family and its relationship to prognosis in pancreatic carcinoma. | Arab J Gastroenterol | 2024 | 39039002 | PubTator, text mining | PubMed |
| [Clinical and bioinformatics analysis of the relationship between LAMA3 DNA methylation expression and platinum resistance and prognosis in epithelial ovarian cancer]. | Zhonghua Fu Chan Ke Za Zhi | 2024 | 38951081 | PubTator, text mining | PubMed |
| Basement membrane-associated gene expression as a predictor of survival in oral cancer. | BMC Cancer | 2024 | 38877482 | PubTator, text mining | PubMed |
| Weighted gene co-expression network analysis and whole genome sequencing identify potential lung cancer biomarkers. | Front Oncol | 2024 | 38854719 | PubTator, text mining | PubMed |
| Descriptive Study of the Clinical and Molecular Features of Epidermolysis Bullosa Patients in a Romanian European Reference Network-Skin Affiliated Reference Center. | Cureus | 2024 | 38803406 | PubTator, text mining | PubMed |
| miRSNP rs188493331: A key player in genetic control of microRNA-induced pathway activation in hypertrophic scars and keloids. | Skin Res Technol | 2024 | 38682767 | PubTator, text mining | PubMed |
| Of LAMA3 and LAMB3: A novel gene therapy for epidermolysis bullosa. | Mol Ther | 2024 | 38631349 | PubTator, text mining | PubMed |
| Molecular Insights Into the Effects of PLLA-SCA on Gene Expression and Collagen Synthesis in Human 3D Skin Models Containing Macrophages. | J Drugs Dermatol | 2024 | 38564382 | PubTator, text mining | PubMed |
| On- and off-target effects of paired CRISPR-Cas nickase in primary human cells. | Mol Ther | 2024 | 38459694 | PubTator, text mining | PubMed |
| Correlation of laminin subunit alpha 3 expression in pancreatic ductal adenocarcinoma with tumor liver metastasis and survival. | Radiol Oncol | 2024 | 38452390 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3909/papers?page=4